Results 101 to 110 of about 12,753 (177)

Assessing the real-world drug safety of sevelamer for hyperphosphatemia: Insights from a comprehensive analysis of the FDA adverse event reporting system (FAERS) database. [PDF]

Medicine (Baltimore)
Shao X, Yang H, Tan C, Liu J, Zhou L.
europepmc   +1 more source

[hypophosphatemia and hyperphosphatemia].

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2006
Atsushi, Fukatsu, Noriyuki, Iehara, Yoshinori, Tanaka   +2 more
openaire   +1 more source

Pseudohypoparathyroidism in a Chinese girl: A case report. [PDF]

J Int Med Res
Zhao XM, Yang JR, Yin H, Yang CQ, Song Y.   +4 more
europepmc   +1 more source

Single-center analysis of etiology and complications in hospitalized children with chronic kidney disease stages 3-5. [PDF]

Front Pediatr
Liang Y, Shen Y, Jiang Y.
europepmc   +1 more source

Emerging treatments and current strategies for mineral, vascular, and bone disorders in chronic kidney disease. [PDF]

World J Nephrol
Ilkun O, Jazayeri F, Kazory A.
europepmc   +1 more source

Impact and mechanism of iron metabolism on vascular calcification. [PDF]

Chin Med J (Engl)
Wang H, Song Y, Qin Q.
europepmc   +1 more source

Hyperphosphatemia as a potential risk factor for arteriovenous fistula dysfunction: A retrospective study in hemodialysis patients. [PDF]

PLoS One
Jiang Y, Cui C, Nan H, Chang T, Li F, Zhang S.   +5 more
europepmc   +1 more source

Association between admission serum phosphate levels and prognosis in post-cardiac arrest patients: a retrospective observational study. [PDF]

BMC Cardiovasc Disord
Fu F, Xu J, Ma L, Ji P.
europepmc   +1 more source

A Risk Developing Prominent Hyperphosphatemia Leading to Renal Failure in Cup‐Like Leukemia

eJHaem
Osamu Imataki, Makiko Uemura, Shumpei Uchida, Akihiro Takeuchi   +3 more
doaj   +1 more source